Consucon is a prescription medication manufactured by Incepta Pharmaceuticals Ltd. in Bangladesh. It contains Gliclazide, a second-generation sulfonylurea used to manage Type 2 Diabetes Mellitus. Consucon works by stimulating the pancreas to release more insulin and improving the body's sensitivity to insulin, thereby helping to control blood sugar levels.